• FDA Requests Heartburn Drug Zantac To Be Pulled From Market Immediately

    1 month ago - By CBS

    The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday.
    The FDA noted that an ongoing investigation has determined that levels of a contaminant in the heartburn medications increase over time and when stored at higher-than-normal temperatures, poses a risk to public health.
    The contaminant, N-nitrosodimethylamine or NDMA, is a probable human carcinogen and the FDA has been investigating levels of it in ranitidine since the...
    Read more ...

     

  • FDA wants heartburn meds off the market due to contamination

    FDA wants heartburn meds off the market due to contamination

    1 month ago - By Star Tribune

    U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought.
    Read more ...

     

  • Zantac, all ranitidine products, to be removed from shelves; FDA cites carcinogen concerns

    1 month ago - By ABC

    The U.S. Food and Drug Administration Wednesday said Zantac should be removed from shelves immediately.
    Read more ...

     

  • U.S. FDA moves to remove all versions of heartburn drug Zantac from market

    1 month ago - By National Post

    The U.S. Food and Drug Administration said on Wednesday it was requesting makers of all versions of heartburn drug Zantac to remove the drugs from the market immediately due to the presence of a probable carcinogen.
    Read more ...